174 related articles for article (PubMed ID: 29452400)
1. Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.
Weinstein ER; Rebman AW; Aucott JN; Johnson-Greene D; Bechtold KT
Sleep; 2018 May; 41(5):. PubMed ID: 29452400
[TBL] [Abstract][Full Text] [Related]
2. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.
Rebman AW; Bechtold KT; Yang T; Mihm EA; Soloski MJ; Novak CB; Aucott JN
Front Med (Lausanne); 2017; 4():224. PubMed ID: 29312942
[TBL] [Abstract][Full Text] [Related]
3. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
[TBL] [Abstract][Full Text] [Related]
4. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?
Aucott JN; Rebman AW; Crowder LA; Kortte KB
Qual Life Res; 2013 Feb; 22(1):75-84. PubMed ID: 22294245
[TBL] [Abstract][Full Text] [Related]
5. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
[TBL] [Abstract][Full Text] [Related]
6. Risk of post-treatment Lyme disease in patients with ideally-treated early Lyme disease: A prospective cohort study.
Aucott JN; Yang T; Yoon I; Powell D; Geller SA; Rebman AW
Int J Infect Dis; 2022 Mar; 116():230-237. PubMed ID: 35066160
[TBL] [Abstract][Full Text] [Related]
7. Development of a foundation for a case definition of post-treatment Lyme disease syndrome.
Aucott JN; Crowder LA; Kortte KB
Int J Infect Dis; 2013 Jun; 17(6):e443-9. PubMed ID: 23462300
[TBL] [Abstract][Full Text] [Related]
8. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
[TBL] [Abstract][Full Text] [Related]
9. CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.
Aucott JN; Soloski MJ; Rebman AW; Crowder LA; Lahey LJ; Wagner CA; Robinson WH; Bechtold KT
Clin Vaccine Immunol; 2016 Sep; 23(9):757-66. PubMed ID: 27358211
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Response in Patients With Post-treatment Lyme Disease Symptoms/Syndrome.
Fitzgerald BL; Graham B; Delorey MJ; Pegalajar-Jurado A; Islam MN; Wormser GP; Aucott JN; Rebman AW; Soloski MJ; Belisle JT; Molins CR
Clin Infect Dis; 2021 Oct; 73(7):e2342-e2349. PubMed ID: 32975577
[TBL] [Abstract][Full Text] [Related]
11. Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease.
Weitzner E; McKenna D; Nowakowski J; Scavarda C; Dornbush R; Bittker S; Cooper D; Nadelman RB; Visintainer P; Schwartz I; Wormser GP
Clin Infect Dis; 2015 Dec; 61(12):1800-6. PubMed ID: 26385994
[TBL] [Abstract][Full Text] [Related]
12. Health care costs, utilization and patterns of care following Lyme disease.
Adrion ER; Aucott J; Lemke KW; Weiner JP
PLoS One; 2015; 10(2):e0116767. PubMed ID: 25650808
[TBL] [Abstract][Full Text] [Related]
13. Posttreatment Lyme disease syndrome.
Aucott JN
Infect Dis Clin North Am; 2015 Jun; 29(2):309-23. PubMed ID: 25999226
[TBL] [Abstract][Full Text] [Related]
14. Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.
Bechtold KT; Rebman AW; Crowder LA; Johnson-Greene D; Aucott JN
Arch Clin Neuropsychol; 2017 Mar; 32(2):129-141. PubMed ID: 28365751
[TBL] [Abstract][Full Text] [Related]
15. Association of small fiber neuropathy and post treatment Lyme disease syndrome.
Novak P; Felsenstein D; Mao C; Octavien NR; Zubcevik N
PLoS One; 2019; 14(2):e0212222. PubMed ID: 30753241
[TBL] [Abstract][Full Text] [Related]
16. Treatment of post-treatment Lyme disease symptoms-a systematic review.
Dersch R; Torbahn G; Rauer S
Eur J Neurol; 2024 Jul; 31(7):e16293. PubMed ID: 38606630
[TBL] [Abstract][Full Text] [Related]
17. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
[TBL] [Abstract][Full Text] [Related]
18. Posttreatment Lyme Disease Syndrome-What It Might Be and What It Is Not.
Schmid H; Heininger U
Pediatr Infect Dis J; 2021 May; 40(5S):S31-S34. PubMed ID: 34042908
[TBL] [Abstract][Full Text] [Related]
19. Depressive symptoms account for differences between self-reported versus polysomnographic assessment of sleep quality in women with myofascial TMD.
Dubrovsky B; Janal MN; Lavigne GJ; Sirois DA; Wigren PE; Nemelivsky L; Krieger AC; Raphael KG
J Oral Rehabil; 2017 Dec; 44(12):925-933. PubMed ID: 28853162
[TBL] [Abstract][Full Text] [Related]
20. Neurocognition in Post-Treatment Lyme Disease and Major Depressive Disorder.
Keilp JG; Corbera K; Gorlyn M; Oquendo MA; Mann JJ; Fallon BA
Arch Clin Neuropsychol; 2019 Jun; 34(4):466-480. PubMed ID: 30418507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
